Clovis Oncology CEO Patrick Mahaffy's 2019 pay rises 10% to $6.9M
Clovis Oncology reports 2019 executive compensation
By ExecPay News
Published: April 24, 2020
Clovis Oncology reported fiscal year 2019 executive compensation information on April 24, 2020.
In 2019, five executives at Clovis Oncology received on average a compensation package of $3.9M, a 50% increase compared to previous year.
Average pay of disclosed executives at Clovis Oncology
Patrick J. Mahaffy, Chief Executive Officer, received $6.9M in total, which increased by 10% compared to 2018. 83% of Mahaffy's compensation, or $5.7M, was in option awards. Mahaffy also received $454K in bonus, $719K in salary, as well as $22K in other compensation.
For fiscal year 2019, the median employee pay was $262,806 at Clovis Oncology. Therefore, the ratio of Patrick J. Mahaffy's pay to the median employee pay was 26 to one.
Paul E. Gross, General Counsel, received a compensation package of $3.6M. 65% of the compensation package, or $2.3M, was in stock awards.
Daniel W. Muehl, Chief Financial Officer, earned $3.6M in 2019, a 137% increase compared to previous year.
Lindsey Rolfe, Chief Medical Officer, received $2.7M in 2019, which increases by 48% compared to 2018.
Gillian C. Ivers-Read, EVP and Chief Regulatory Officer, earned $2.6M in 2019, a 50% increase compared to previous year.
Related executives
You may also like
Source: SEC filing on April 24, 2020.